biotech · Moderately to Severely Active Ulcerative Colitis · Inflammatory Bowel Diseases · ODTX
Odyssey Therapeutics
Odyssey Therapeutics is a biotech organization headquartered in San Ramon, USA. It trades on NYSE under ticker ODTX. Primary therapeutic focus areas include Moderately to Severely Active Ulcerative Colitis, Inflammatory
San Ramon, USA HQ
3 Employees
Public company Type
ODTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Ramon, USA
- Employees
- 3
- Programs
- 4
- Drugs
- 6
- Patents
- 1
OD-07656
Phase 2 · small molecule · Ulcerative Colitis (UC)
OD-07656 for Ulcerative Colitis (UC) is a Phase 2 program (small_molecule) at Odyssey Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code OD-07656-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Odyssey Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Ulcerative Colitis (UC)
- Status
- active
- Trials
- 1